Lachlan Moldenhauer
Adelaide University, SA, Australia
Dr Lachlan Moldenhauer received his PhD from the University of Adelaide in 2008, and is currently based at the Robinson Research Institute, Adelaide University. His research investigates the mechanisms by which the maternal immune system establishes immune tolerance at the outset of pregnancy to allow for embryo implantation, placentation and fetal development. In particular, the activation of maternal regulatory T cells during the peri-conception period and how inappropriate priming of the maternal T cell repertoire impacts on fetal development and pathologies of pregnancy.
Presentations this author is a contributor to:
Toll-like receptor 4 antagonist (+)-naloxone prevents infection-driven fetal loss and preterm labour in mice (#27)
10:45 AM
Lachlan M Moldenhauer
SRB Orals - Immune cells & Inflammation
Progesterone regulates regulatory T cell abundance and phenotype in the hormone environment of early pregnancy (#126)
5:00 PM
Ella S Green
SRB - David Healy New Investigator Award Finalists
Novel non-competitive Interleukin-1 receptor antagonist prevents LPS-induced preterm birth (#28)
11:00 AM
Peck Y Chin
SRB Orals - Immune cells & Inflammation
ESA-SRB 2015*